PORTAL VEIN THROMBOSIS
Clinical trials for PORTAL VEIN THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new PORTAL VEIN THROMBOSIS trials appear
Sign up with your email to follow new studies for PORTAL VEIN THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough-to-treat liver cancer
Disease control CompletedThis study tested a combination of proton beam radiotherapy followed by two drugs (Tecentriq and Avastin) in 63 adults with advanced liver cancer that had spread into the portal vein. The goal was to see if this approach could help control the cancer and improve survival. Partici…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy shows promise for tough liver cancer
Disease control CompletedThis study tested a three-drug combination for people with advanced liver cancer that has spread into the portal vein (a major blood vessel). The treatment adds a liver-directed chemotherapy infusion to two standard drugs (lenvatinib and a PD-1 inhibitor). The goal was to see if …
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Stent procedure eases severe symptoms in cancer patients with blocked veins
Symptom relief CompletedThis study looked at placing a small metal tube (stent) into the portal vein of 63 cancer patients whose vein was blocked by a tumor. The goal was to relieve serious symptoms like fluid buildup in the belly or bleeding in the gut. The procedure was done through a needle in the li…
Matched conditions: PORTAL VEIN THROMBOSIS
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Computer model helps cirrhosis patients get blood thinner doses right faster
Knowledge-focused CompletedThis study tested whether a computer program (Simcyp) could help doctors choose the right starting dose of warfarin, a blood thinner, for 21 patients with liver cirrhosis and a blood clot in the portal vein. The goal was to see if the program helped patients reach a safe, effecti…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC